These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33567808)

  • 1. Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates.
    Slingsby MHL; Vijey P; Tsai IT; Roweth H; Couldwell G; Wilkie AR; Gaus H; Goolsby JM; Okazaki R; Terkovich BE; Semple JW; Thon JN; Henry SP; Narayanan P; Italiano JE
    Haematologica; 2022 Feb; 107(2):519-531. PubMed ID: 33567808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of 2'-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials.
    Crooke ST; Baker BF; Witztum JL; Kwoh TJ; Pham NC; Salgado N; McEvoy BW; Cheng W; Hughes SG; Bhanot S; Geary RS
    Nucleic Acid Ther; 2017 Jun; 27(3):121-129. PubMed ID: 28145801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Assessment of the Clinical Performance of GalNAc
    Crooke ST; Baker BF; Xia S; Yu RZ; Viney NJ; Wang Y; Tsimikas S; Geary RS
    Nucleic Acid Ther; 2019 Feb; 29(1):16-32. PubMed ID: 30570431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of GalNAc
    Baker BF; Xia S; Partridge W; Engelhardt JA; Tsimikas S; Crooke ST; Bhanot S; Geary RS
    Nucleic Acid Ther; 2024 Feb; 34(1):18-25. PubMed ID: 38227794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of thrombocytopenia caused by cholesterol-conjugated antisense oligonucleotides.
    Harada K; Furukawa H; Kohara H; Nishimura K; Komori H; Okai Y; Arai Y; Yamamoto Y; Yamamoto K; Imanishi A; Shinozawa T
    Toxicol In Vitro; 2023 Jun; 89():105569. PubMed ID: 36801361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of 2'-O-Methoxyethyl Oligonucleotides on Renal Function in Humans.
    Crooke ST; Baker BF; Pham NC; Hughes SG; Kwoh TJ; Cai D; Tsimikas S; Geary RS; Bhanot S
    Nucleic Acid Ther; 2018 Feb; 28(1):10-22. PubMed ID: 29185862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in the Tolerability Profile of 2'-
    Partridge W; Xia S; Kwoh TJ; Bhanot S; Geary RS; Baker BF
    Nucleic Acid Ther; 2021 Dec; 31(6):417-426. PubMed ID: 34242101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny.
    Valenzuela A; Ayuso M; Buyssens L; Bars C; Van Ginneken C; Tessier Y; Van Cruchten S
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Assessment of Phase 2 Data on GalNAc
    Baker BF; Xia S; Partridge W; Kwoh TJ; Tsimikas S; Bhanot S; Geary RS
    Nucleic Acid Ther; 2023 Jan; 33(1):72-80. PubMed ID: 36454263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide targeting of thrombopoietin represents a novel platelet depletion method to assess the immunomodulatory role of platelets.
    Barrett TJ; Wu BG; Revenko AS; MacLeod AR; Segal LN; Berger JS
    J Thromb Haemost; 2020 Jul; 18(7):1773-1782. PubMed ID: 32227586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry.
    Zellweger T; Miyake H; Cooper S; Chi K; Conklin BS; Monia BP; Gleave ME
    J Pharmacol Exp Ther; 2001 Sep; 298(3):934-40. PubMed ID: 11504787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides and nucleic acids generate hypersensitive platelets.
    Zaslavsky A; Adams M; Cao X; Yamaguchi A; Henderson J; Busch-Østergren P; Udager A; Pitchiaya S; Tourdot B; Kasputis T; Church SJ; Lee SK; Ohl S; Patel S; Morgan TM; Alva A; Wakefield TW; Reichert Z; Holinstat M; Palapattu GS
    Thromb Res; 2021 Apr; 200():64-71. PubMed ID: 33540294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C3d/C4d Deposition on Platelets Correlates with 2'-O-Methoxyethyl Antisense Oligonucleotide-Induced Thrombocytopenia in Monkeys.
    Shen L; Wong A; Oneda S; Curtis BR; Schroeder J; Zanardi T; Engelhardt JA; Henry SP; Narayanan P
    Nucleic Acid Ther; 2023 Jun; 33(3):209-225. PubMed ID: 37093125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Mouse Diversity Panel Identifies Genetic Architecture Associated with the Acute Antisense Oligonucleotide-Mediated Inflammatory Response to a 2'-
    Pirie E; Cauntay P; Fu W; Ray S; Pan C; Lusis AJ; Hsiao J; Burel SA; Narayanan P; Crooke RM; Lee RG
    Nucleic Acid Ther; 2019 Oct; 29(5):266-277. PubMed ID: 31368839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.
    Koller E; Propp S; Zhang H; Zhao C; Xiao X; Chang M; Hirsch SA; Shepard PJ; Koo S; Murphy C; Glazer RI; Dean NM
    Cancer Res; 2006 Feb; 66(4):2059-66. PubMed ID: 16489005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice Lacking the Inhibitory Collagen Receptor LAIR-1 Exhibit a Mild Thrombocytosis and Hyperactive Platelets.
    Smith CW; Thomas SG; Raslan Z; Patel P; Byrne M; Lordkipanidzé M; Bem D; Meyaard L; Senis YA; Watson SP; Mazharian A
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):823-835. PubMed ID: 28336561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.
    Flierl U; Nero TL; Lim B; Arthur JF; Yao Y; Jung SM; Gitz E; Pollitt AY; Zaldivia MT; Jandrot-Perrus M; Schäfer A; Nieswandt B; Andrews RK; Parker MW; Gardiner EE; Peter K
    J Exp Med; 2015 Feb; 212(2):129-37. PubMed ID: 25646267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of activated platelets and platelet-leukocyte aggregates in horses.
    Weiss DJ; Evanson OA
    Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotersen and severe thrombocytopenia: 2 case reports and review.
    Domínguez Senín L; Borrachero Garro C; Sánchez Gómez E; Santos-Rubio MD
    Int J Clin Pharmacol Ther; 2022 Jul; 60(7):311-316. PubMed ID: 35343431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.